Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2022-07-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-022-00707-4 |
| _version_ | 1828190484849229824 |
|---|---|
| author | Hassan B. Alkhateeb Razan Mohty Patricia Greipp Radhika Bansal Matthew Hathcock Allison Rosenthal Hemant Murthy Mohamed Kharfan-Dabaja Jose C. Bisneto Villasboas Nora Bennani Stephen M. Ansell Mrinal M. Patnaik Mark R. Litzow Rong He Dong Chen Aref Al-Kali Saad S. Kenderian Yi Lin Mithun Vinod Shah |
| author_facet | Hassan B. Alkhateeb Razan Mohty Patricia Greipp Radhika Bansal Matthew Hathcock Allison Rosenthal Hemant Murthy Mohamed Kharfan-Dabaja Jose C. Bisneto Villasboas Nora Bennani Stephen M. Ansell Mrinal M. Patnaik Mark R. Litzow Rong He Dong Chen Aref Al-Kali Saad S. Kenderian Yi Lin Mithun Vinod Shah |
| author_sort | Hassan B. Alkhateeb |
| collection | DOAJ |
| first_indexed | 2024-04-12T08:23:07Z |
| format | Article |
| id | doaj.art-7de77bbecbfe4425ac445e6691979e5a |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-04-12T08:23:07Z |
| publishDate | 2022-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-7de77bbecbfe4425ac445e6691979e5a2022-12-22T03:40:30ZengNature Publishing GroupBlood Cancer Journal2044-53852022-07-011271510.1038/s41408-022-00707-4Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin LymphomaHassan B. Alkhateeb0Razan Mohty1Patricia Greipp2Radhika Bansal3Matthew Hathcock4Allison Rosenthal5Hemant Murthy6Mohamed Kharfan-Dabaja7Jose C. Bisneto Villasboas8Nora Bennani9Stephen M. Ansell10Mrinal M. Patnaik11Mark R. Litzow12Rong He13Dong Chen14Aref Al-Kali15Saad S. Kenderian16Yi Lin17Mithun Vinod Shah18Division of Hematology, Mayo ClinicDepartment of Hematology/Oncology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology/Oncology, Mayo ClinicDepartment of Hematology/Oncology, Mayo ClinicDepartment of Hematology/Oncology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematopathology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo Clinichttps://doi.org/10.1038/s41408-022-00707-4 |
| spellingShingle | Hassan B. Alkhateeb Razan Mohty Patricia Greipp Radhika Bansal Matthew Hathcock Allison Rosenthal Hemant Murthy Mohamed Kharfan-Dabaja Jose C. Bisneto Villasboas Nora Bennani Stephen M. Ansell Mrinal M. Patnaik Mark R. Litzow Rong He Dong Chen Aref Al-Kali Saad S. Kenderian Yi Lin Mithun Vinod Shah Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma Blood Cancer Journal |
| title | Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma |
| title_full | Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma |
| title_fullStr | Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma |
| title_full_unstemmed | Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma |
| title_short | Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma |
| title_sort | therapy related myeloid neoplasms following chimeric antigen receptor t cell therapy for non hodgkin lymphoma |
| url | https://doi.org/10.1038/s41408-022-00707-4 |
| work_keys_str_mv | AT hassanbalkhateeb therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT razanmohty therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT patriciagreipp therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT radhikabansal therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT matthewhathcock therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT allisonrosenthal therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT hemantmurthy therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT mohamedkharfandabaja therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT josecbisnetovillasboas therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT norabennani therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT stephenmansell therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT mrinalmpatnaik therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT markrlitzow therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT ronghe therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT dongchen therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT arefalkali therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT saadskenderian therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT yilin therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma AT mithunvinodshah therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma |